Caplacizumab for congenital thrombotic thrombocytopenic purpura

被引：6
|
作者：
Boothby, Aaron [1 ]
Mazepa, Marshall [1 ]
机构：
[1] Univ Minnesota, Sch Med, Dept Med, 420 Delaware St SE,MMC 480, Minneapolis, MN 55455 USA
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2022年 / 97卷 / 11期
关键词：
D O I：
10.1002/ajh.26693
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E420 / E421
页数：2
相关论文
共 50 条
  • [31] Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use
    Blair, Hannah A.
    Lyseng-Williamson, Katherine A.
    DRUGS & THERAPY PERSPECTIVES, 2019, 35 (06) : 263 - 270
  • [32] Intracranial hemorrhage in immune thrombotic thrombocytopenic purpura treated with caplacizumab
    Schofield, Jeremy
    Shaw, Rebecca J.
    Lester, Will
    Thomas, Will
    Toh, Cheng-Hock
    Dutt, Tina
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (08) : 1922 - 1925
  • [33] Caplacizumab to treat immune-mediated thrombotic thrombocytopenic purpura
    Poullin, P.
    Bornet, C.
    Veyradier, A.
    Coppo, P.
    DRUGS OF TODAY, 2019, 55 (06) : 367 - 376
  • [34] Illustrated treatment of refractory immune thrombotic thrombocytopenic purpura with caplacizumab
    Tse, Brandon
    Buchholz, Megan
    Pavenski, Katerina
    BMJ CASE REPORTS, 2021, 14 (08)
  • [35] CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA IN CHILDREN
    Shutova, A. D.
    Kalinina, I. I.
    Suntsova, E., V
    Roikina, E., V
    Galstyon, G. M.
    Smetanina, N. S.
    Maschan, A. A.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2023, 68 (04): : 443 - 455
  • [36] Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura
    Chander, Deepak P.
    Loch, Michelle M.
    Cataland, Spero R.
    George, James N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01): : 92 - 94
  • [37] How should caplacizumab be used for treatment of immune thrombotic thrombocytopenic purpura?
    Zheng, Lucy
    Zheng, X. Long
    ANNALS OF BLOOD, 2023, 8
  • [38] Correction to: Caplacizumab in acquired thrombotic thrombocytopenic purpura: a profile of its use
    Hannah A. Blair
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2019, 35 : 459 - 459
  • [39] Successful use of a second course of caplacizumab in relapsed thrombotic thrombocytopenic purpura
    Shaffer, Jon
    Grove, Angela
    PLATELETS, 2022, 33 (05) : 790 - 791
  • [40] Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era
    del Rio-Garma, Julio
    Bobillo, Sabela
    de la Rubia, Javier
    Pascual, Cristina
    Garcia-Candel, Faustino
    Garcia-Gala, Jose M.
    Gonzalez, Reyes
    Abril, Laura
    Vidan, Julia
    Gomez, Maria Jesus
    Pena, Francisco
    Arbona, Cristina
    Martin-Sanchez, Jesus
    Moreno, Gemma
    Romon, Inigo
    Viejo, Aurora
    Oliva, Ana
    Linares, Monica
    Salinas, Ramon
    Perez, Sonia
    Garcia-Erce, Jose A.
    Pereira, Arturo
    ANNALS OF HEMATOLOGY, 2022, 101 (01) : 59 - 67
12345